LIBALAKS

This brand name is authorized in Turkey.

Active ingredients

The drug LIBALAKS contains a combination of these active pharmaceutical ingredients (APIs):

1	Sorbitol UNII 506T60A25R - SORBITOL
	Read more about Sorbitol
2	Glycerol UNII PDC6A3C0OX - GLYCERIN
	Glycerol has uses as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to a colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer.
	Read more about Glycerol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AG20	Combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
TR	İlaç ve Tıbbi Cihaz Kurumu	8699510920100